GlassScriptPhysician profile
Robert J Bowles
NPI 1336330554
$778.97
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2022: $288 · 2023: $219 · 2024: $37.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $298.02 | 2019-2022 | |
| Intuitive Surgical, INC. | $170.35 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $108.99 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Boston Scientific Corporation | $86.56 | 2019 | |
| Sanara Medtech INC. | $59.05 | 2023 | Celleraterx |
| Smith+Nephew, INC. | $40.93 | 2022-2024 | Grafix Pl, Stravix |
| Organogenesis INC. | $15.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.